glp-1 study Another milestone in the evolution of GLP-1-based diabetes therapies Penn researchers say inconsistent GLP1
Description
In February 2025, the number of Ozempic lawsuit cases rose to 1,443, reflecting an increase of 112 cases compared to January 2025, where the total stood at 1,331

For patients already using a GLP-1 receptor agonist but needing stronger blood sugar and weight control, tirzepatide may offer added benefits because of its dual-action mechanism

Thats part of the care

Semaglutide has been associated with early worsening of diabetic retinopathy in clinical trials

This participant had a corresponding large reduction in their GAD-7 score of 10 points and a drop in HbA1c from 84 to 68 mmol/mol
